In a phase 3 trial, 81% of wounds treated with autologous cell sheet-based gene therapy showed ≥ 50% healing at 6 months, ...

The World Health Organization estimates that approximately 2.2 billion cases have been prevented between 2000 and 2023.

In this week's Texas Border Watch, exchange houses are facing a battle, the DoD gives insight into military border operations ...

You have this convergence of crises,” says Dr. Angelle Desiree LaBeaud. Here’s what that means and how she and others are ...

A newly published study in the Journal of Medical Entomology provides critical insights into the emergence of babesiosis in ...

This expanded offering supports standardized, high-precision quality control (QC) workflows and strengthens the position of QIAGEN as a trusted partner for quality control, supporting biotech and ...

Siren said proceeds will go toward investigational new drug (IND)-enabling animal studies and clinical-grade production of ...

Nigeria, Kebbi and Yobe stand out in Nigeria for their high malaria prevalence, each facing unique challenges in their fight against the disease.

Discover six hemophilia companies developing new treatments for the genetic bleeding disorder, from gene therapies to RNAi therapies.

Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...

The Enugu State Commissioner for Health, Emmanuel Obi has appealed to government at all levels, non-government organisations ...